DRV vs. AZN

In the year-to-date period, DRV achieves a -12.84% return, which is significantly lower than AZN's 12.71% return. Over the past 10 years, DRV has underperformed AZN with an annualized return of -31.44%, while AZN has yielded a comparatively higher 11.48% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Real Estate Bear 3x Shares (DRV) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current DRV Sharpe Ratio is -0.67, which is lower than the AZN Sharpe Ratio of -0.14. The chart below compares the historical Sharpe Ratios of DRV and AZN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

DRV's dividend yield for the trailing twelve months is around 4.94%, more than AZN's 2.10% yield.

The maximum DRV drawdown since its inception was -99.99%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for DRV and AZN.

Direxion Daily Real Estate Bear 3x Shares (DRV) has a higher volatility of 14.18% compared to AstraZeneca PLC (AZN) at 8.32%. This indicates that DRV's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.